MBCL-50. DISMAL OUTCOME OF HIGH RISK MEDULLOBLASTOMA TREATED WITH CHEMOTHERAPY FIRST APPROACH IN MALAYSIA

INTRODUCTION: Patients with high risk medulloblastoma are treated either with high dose chemotherapy or hyperfractionated radiotherapy. Both approaches are not feasible in resource-limited countries. POG9031 trial has reported favourable outcome for high risk medulloblastoma using standard chemother...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Quah, Shiao Wei, Rahman, E J Abdul, Ibrahim, H Mohd, Muda, Z, Othman, I S, Unni, M N Mohamed, Gunasagaran, K, Ang, M P, Goh, C B, Teh, K H
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Medulloblastoma (Clinical)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715103/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.519
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars